Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Physician-initiated, Prospective, Multi-center，Observational Study: The Efficacy of Endovascular Treatment in Femoropopliteal Occlusive Disease (FPOD) With TransAtlantic InterSociety Consensus (TASC) C and D Lesions

NCT04698304 is registered in ClinicalTrials.gov with RenJi Hospital as lead sponsor.

NCT NCT04698304
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04698304 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Physician-initiated, Prospective, Multi-center，Observational Study: The Efficacy of Endovascular Treatment in Femoropopliteal Occlusive Disease (FPOD) With TransAtlantic InterSociety Consensus (TASC) C and D Lesions
Lead sponsor
RenJi Hospital
Phase
Observational
Overall status
Completed
Start date
December 1, 2020
Completion date
August 31, 2026
Enrollment
1,518 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

femoropopliteal occlusive disease